Law360 (September 30, 2019, 4:32 PM EDT) — A Florida CBD retailer and its parent companies have been hit with a proposed class action claiming their products do not contain the advertised amounts of cannabidiol, and that they are cheating customers with their false and deceptive labels.
Kathryn Potter, a Miami resident, claims in Friday’s complaint that products purchased from Diamond CBD had “significantly lower” amounts of CBD than what was stated on their labels. Her complaint against Diamond and its parent companies First Capital Venture Co. and PotNetwork Holdings Inc. includes one count of unjust enrichment and one count of violation of the Florida Deceptive and Unfair Trade…
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!
We study the effects of cannabidiol (CBD), a non-psychoactive component of cannabis that does not produce the high associated with smoking or using it."There is a lot of debate on the health effects of marijuana and the use of cannabinoids, which are a group of compounds found in marijuana that have anti-inflammatory, pain-relieving, anti-nausea and anti-emetic properties. However, there is a lack of solid scientific evidence to guide us in the application of cannabis therapeutics."